INS and diabetes mellitus: Using a relatively recently available ultrasensitive C-peptide assay in a cross-sectional study we demonstrated insulin microsecretion (detectable C-peptide levels) in 55.3% of people with diabetes, including 64.1% of adults and 34.0% of youth with diabetes.